| Multi-analyte Blood Test Clinical Trial (NCT05199259) | Helio Genomics | 2022-03-01 |
| HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation (NCT04455932) | Concord Repatriation General Hospital | 2022-01-01 |
| Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study (NCT05202015) | Charite University, Berlin, Germany | 2022-01-01 |
| ICIs With and Without MWA in Advanced Hepatocellular Carcinoma (NCT06581497) | The First People's Hospital of Neijiang | 2022-01-01 |
| Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis (NCT05022628) | Anhui Provincial Hospital | 2021-09-30 |
| cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC (NCT05025592) | Peking University Cancer Hospital & Institute | 2021-09-10 |
| GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma (NCT05178043) | Suzhou Kintor Pharmaceutical Inc, | 2021-08-01 |
| Artificial Intelligence and Hepatocellular Carcinoma (NCT05637788) | Humanitas Clinical and Research Center | 2021-07-01 |
| The Utility of Breath Biopsy as a Screening Tool for HCC (NCT04326491) | University of Aberdeen | 2021-06-20 |
| Artificial Intelligence vs. LIRADS in Diagnosing HCC on CT (NCT04843176) | The University of Hong Kong | 2021-03-19 |
| Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC (NCT04522544) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-12-15 |
| Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study (NCT04640363) | Chinese PLA General Hospital | 2020-12-01 |
| Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection (NCT04682210) | Sun Yat-sen University | 2020-12-01 |
| TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma (NCT04988945) | The University of Hong Kong | 2020-12-01 |
| Cabozantinib in Hepatocellular Carcinoma (NCT04588051) | Stephen Chan Lam | 2020-11-01 |
| The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma (NCT04542837) | Peking University Cancer Hospital & Institute | 2020-09-11 |
| Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma (NCT04472767) | University of California, Irvine | 2020-08-07 |
| Optimizing Y90 Therapy for Radiation Lobectomy (NCT04390724) | Northwestern University | 2020-07-17 |
| Neoadjuvant Anti-PD1 in HCC (NCT05471674) | Dr Tan-to CHEUNG | 2020-07-03 |
| Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC (NCT04611373) | The First Affiliated Hospital of Zhengzhou University | 2020-05-01 |
| Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant (NCT03960008) | Lahey Clinic | 2020-03-01 |
| GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC (NCT04251117) | Geneos Therapeutics | 2020-03-01 |
| Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation (NCT04232722) | Zhejiang University | 2020-01-01 |
| Composite Warming Strategy Reduces Intraoperative Hypothermia in Open Hepatectomy for Liver Cancer (NCT06766773) | The First People's Hospital of Neijiang | 2020-01-01 |
| Dual Arterial Phase Liver CT in Patients With Suspected Portal Hypertension (NCT04195971) | Seoul National University Hospital | 2019-12-26 |
| Renal Protocol Protection in CKD Patients (NCT04024514) | Seoul National University Hospital | 2019-12-24 |
| Low-dose Y90 Treatment Planning for HCC (NCT04172714) | Emory University | 2019-12-16 |
| PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT (NCT04165174) | Huazhong University of Science and Technology | 2019-12-01 |
| A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors (NCT04172506) | Akeso | 2019-09-10 |
| Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation (NCT04123340) | Leiden University Medical Center | 2019-08-26 |
| Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma (NCT03985644) | Zhejiang University | 2019-07-01 |
| Netrin-1 & Hepatocellular Carcinoma HCC (NCT04766736) | Hospices Civils de Lyon | 2019-07-01 |
| Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC) (NCT03893695) | Suzhou Kintor Pharmaceutical Inc, | 2019-05-25 |
| Novel Treatment of Advanced Hepatocellular Carcinoma (NCT03950518) | The First Affiliated Hospital of Zhengzhou University | 2019-04-10 |
| Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy (NCT03817736) | The University of Hong Kong | 2019-03-01 |
| Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC (NCT06461936) | Chen Xiaoping | 2019-01-01 |
| VETC is an Effective Marker for Postoperative Adjuvant Immunotherapy (NCT06253364) | Chen Xiaoping | 2019-01-01 |
| Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. (NCT02715492) | Sherief Abd-Elsalam | 2018-10-01 |
| A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC (NCT03601598) | Harbin Medical University | 2018-07-30 |
| Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study (NCT03437382) | Leiden University Medical Center | 2018-07-01 |
| Pembrolizumab in Hepatocellular Carcinoma (NCT03419481) | CCTU | 2018-04-30 |
| Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres (NCT05227482) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2018-04-10 |
| Risk of HCC in Cirrhotic Patients Post DAAs Ttt (NCT03414554) | Assiut University | 2018-02-01 |
| Multidisciplinary Management of HCC in Elderly Patients (NCT03875417) | Azienda Policlinico Umberto I | 2018-01-01 |
| Evaluation of Risk of hEpatocellular Carcinoma (NCT06523179) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2018-01-01 |
| The Efficacy of Hepatectomy or TILA-TACE in Patients With Resectable Hepatocellular Carcinoma (NCT03314532) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2017-11-01 |
| Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation (NCT02935478) | St. Louis University | 2017-10-18 |
| A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver (NCT02966223) | Indiana University | 2017-08-17 |
| Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC (NCT03199807) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2017-07-20 |
| Treatment of Intermediate-stage Hepatocellular Carcinoma (NCT03274427) | The First Affiliated Hospital of Zhengzhou University | 2017-07-18 |
| Treatment of Advanced Hepatocellular Carcinoma (NCT03278444) | The First Affiliated Hospital of Zhengzhou University | 2017-07-18 |
| Efficacy and Safety of Sorafenib as Adjuvant and Latter Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma (NCT03097848) | Southwest Hospital, China | 2017-05-04 |
| ERAS Program Improves Recovery of HCC Patient Undergoing Hepatectomy (NCT03104920) | feng xiaobin | 2017-03-27 |
| Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC (NCT02187081) | Southwest Hospital, China | 2017-03-15 |
| Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients. (NCT02971696) | Ain Shams University | 2016-12-01 |
| Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening (NCT02833298) | Icahn School of Medicine at Mount Sinai | 2016-11-01 |
| Statin With Palliative Therapy for HCC (NCT02785874) | Taipei Medical University WanFang Hospital | 2016-09-01 |
| MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma (NCT02575339) | Kathy Miller | 2016-07-18 |
| LifePearl-Doxo Pharmacokinetic (PK) Study (NCT02548780) | Terumo Europe N.V. | 2016-04-01 |
| Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma (NCT02645981) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2016-03-01 |
| Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors (NCT02705105) | Kyowa Kirin, Inc. | 2016-02-01 |
| A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction (NCT02659852) | Yonsei University | 2016-01-01 |
| 18F-FDG PET in HCC Patients Candidate to Treatment With Sorafenib (NCT02977754) | Istituto Clinico Humanitas | 2016-01-01 |
| p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma (NCT02561546) | Shenzhen SiBiono GeneTech Co.,Ltd | 2015-12-01 |
| Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization (NCT02471313) | National Institutes of Health Clinical Center (CC) | 2015-06-12 |
| Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC) (NCT02898415) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-06-01 |
| OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI (NCT02415283) | Beijing 302 Hospital | 2015-05-01 |
| Small and Steatotic Hepatocellular Carcinoma (NCT03428321) | University Hospital, Montpellier | 2015-01-01 |
| Combined Treatment of RFA and Sorafenib on Recurrent HCC (NCT01470495) | Southwest Hospital, China | 2015-01-01 |
| Non Transplantable Recurrence After Percutaneous Thermal Ablation of HCC (NCT05202184) | University Hospital, Montpellier | 2015-01-01 |
| Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L (NCT02232490) | Immunitor LLC | 2015-01-01 |
| ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy (NCT04173520) | Egyptian Liver Hospital | 2015-01-01 |
| A Study of HCC High Risk Group Using Two Surveillance Tools (NCT02675920) | Seoul National University Hospital | 2014-11-28 |
| Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors (NCT03176485) | University of Arizona | 2014-10-17 |
| Open Label Trial of Immunotherapy for Advanced Liver Cancer (NCT02256514) | Immunitor LLC | 2014-09-01 |
| Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant (NCT02182687) | Lahey Clinic | 2014-06-01 |
| Radiofrequency Ablation Using Cooled-Wet Electrode (NCT02675894) | Seoul National University Hospital | 2014-04-14 |
| Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma (NCT02229071) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2014-04-01 |
| Monopolar Radiofrequency Ablation Using a Dual Switching System and a Separable Clustered Electrode (Octopus®) (NCT02675881) | Seoul National University Hospital | 2013-08-05 |
| Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) (NCT01871545) | Icahn School of Medicine at Mount Sinai | 2013-06-01 |
| A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (NCT01387555) | Jennerex Biotherapeutics | 2011-10-08 |
| A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer (NCT01356628) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-05-25 |
| ISP-TACE Versus TACE for HCC With PVTT (NCT03108248) | Zhongda Hospital | 2011-01-01 |
| Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC) (NCT01265576) | Vicus Therapeutics | 2010-12-01 |
| Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT (NCT02985034) | Seoul National University Hospital | 2010-10-01 |
| Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy (NCT04530240) | University of Bologna | 2010-08-01 |
| A Novel MSE Score to Predict rHCC Patients (NCT05450874) | Tongji Hospital | 2010-02-01 |
| Added Value of Gadoxetic Acid-enhanced Liver MRI (NCT03045419) | Seoul National University Hospital | 2009-12-29 |
| Hepatectomy for Early-stage HCC Patients With CSPH (NCT05402644) | Tongji Hospital | 2009-12-01 |
| Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria (NCT04069416) | Ain Shams University | 2004-01-01 |